Towards equitable and sustainable availability of blood products in Zimbabwe : an analysis of strengths, weaknesses, opportunities and challenges

Show simple item record

dc.contributor.author Denhere, K.
dc.contributor.author Dzinamarira, Tafadzwa
dc.contributor.author Tungwarara, Nigel
dc.contributor.author Kampira, V.
dc.contributor.author Chitungo, Itai
dc.contributor.author Mataruka, K.
dc.contributor.author Mukwenha, Solomon
dc.contributor.author Musuka, Godfrey
dc.contributor.author Murewanhema, Grant
dc.date.accessioned 2022-12-15T05:39:59Z
dc.date.issued 2022-08
dc.description.abstract Blood transfusion can be a lifesaving intervention in a number of medical emergencies. To attain sustainable and equitable availability of blood products, it is important to understand the strengths, weaknesses, opportunities, and challenges of the national blood services programme. We, therefore, with this letter to the editor, discuss some of the strengths, weaknesses, opportunities and threats to the Zimbabwean programme since its inception. Despite several strengths and opportunities that the national blood services of Zimbabwe (NBSZ) leverages on, we argue that among other challenges, donor shortages and an upsurge of transfusion transmittable infections in the eligible donor population continue to be the biggest threats to the achievement of the programme objectives. These can be addressed through expanding the blood donor base and the catchment area. Additionally, improving the level of knowledge and attitude towards blood donation in the communities is critical for driving the sustainable and equitable distribution of safe blood products to the population. en_US
dc.description.department School of Health Systems and Public Health (SHSPH) en_US
dc.description.embargo 2023-08-17
dc.description.librarian hj2022 en_US
dc.description.uri https://www.journals.elsevier.com/transfusion-clinique-et-biologique en_US
dc.identifier.citation Denhere, K., Dzinamarira, T., Tungwarara, N. et al. 2022, 'Towards equitable and sustainable availability of blood products in Zimbabwe : an analysis of strengths, weaknesses, opportunities and challenges', Transfusion Clinique et Biologique, vol. 29, no. 3, pp. 273-275, doi : 10.1016/j.tracli.2022.06.006. en_US
dc.identifier.issn 1246-7820
dc.identifier.other 10.1016/j.tracli.2022.06.006
dc.identifier.uri https://repository.up.ac.za/handle/2263/88816
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.rights © 2022 Société francaise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. Notice : this is the author’s version of a work that was accepted for publication in Transfusion Clinique et Biologique. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Transfusion Clinique et Biologique, vol. 29, no. 3, pp. 273-275, 2022, doi : 10.1016/j.tracli.2022.06.006. en_US
dc.subject Blood en_US
dc.subject Blood transfusion en_US
dc.subject Blood products en_US
dc.subject Healthcare en_US
dc.title Towards equitable and sustainable availability of blood products in Zimbabwe : an analysis of strengths, weaknesses, opportunities and challenges en_US
dc.type Postprint Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record